United Kingdom · Question · Written question
UIN 9805
Burosumab
Introduced
16 January 2024
Last action
19 January 2024 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
19 January 2024
Summary
To ask the Secretary of State for Health and Social Care, whether she has had discussions with NICE on their decision not to recommend using burosumab in the treatment of (a) X-linked hypophosphatemia and (b) related disorders in adults.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
16 January 2024
Written question
To ask the Secretary of State for Health and Social Care, whether she has had discussions with NICE on their decision not to recommend using burosumab in the treatment of (a) X-linked hypophosphatemia and (b) related disorders in adults.
Source: Commons
19 January 2024
Answer
The Department has had no discussions with colleagues in the National Institute for Health and Care Excellence (NICE) regarding burosumab. NICE is an independent body and its recommendations are developed in accordance with its published methods and proce...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2024-01-16/9805
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1682497
- uk · wq-1682497 · source updated 19 January 2024